Mizuho Securities USA’s Bristol-Myers Squibb BMY Stock Holding History

Mizuho Securities USA’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.21M	Buy	159,871 +36,757	+30%	+$2.11M	0.15%	122
2026 Q1	$7.47M	Sell	123,114 -25,116	-17%	-$1.46M	0.18%	113
2025 Q4	$7.29M	Sell	148,230 -18	-0%	-$866	0.12%	144
2025 Q3	$6.99M	Buy	148,248 +7,602	+5%	+$355K	0.14%	141
2025 Q2	$6.51M	Sell	140,646 -21,841	-13%	-$1.07M	0.14%	148
2025 Q1	$9.91M	Sell	162,487 -29,738	-15%	-$1.73M	0.21%	98
2024 Q4	$10.9M	Buy	192,225 +60,759	+46%	+$3.39M	0.2%	94
2024 Q3	$6.8M	Sell	131,466 -24,827	-16%	-$1.16M	0.15%	122
2024 Q2	$6.49M	Buy	+156,293	New	+$6.99M	0.14%	130
2020 Q3	–	Sell	-4,557	Closed	-$268K	–	168
2020 Q2	$268K	Buy	+4,557	New	+$273K	0.02%	123
2017 Q2	–	Sell	-362,100	Closed	-$20.4M	–	176
2017 Q1	$20.4M	Buy	+362,100	New	+$19.9M	1.11%	5
2016 Q3	–	Sell	-92,300	Closed	-$6.79M	–	205
2016 Q2	$6.79M	Buy	+92,300	New	+$6.52M	1.08%	16
2015 Q1	–	Sell	-149,800	Closed	-$8.84M	–	239
2014 Q4	$8.84M	Buy	+149,800	New	+$8.45M	0.87%	29

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mizuho Securities USA's BMY Position: Q2 2026 in Review

Mizuho Securities USA increased its Bristol-Myers Squibb (BMY) stake by 30% in Q2 2026, buying an estimated $2.11M and bringing the position to 159,871 shares worth $9.21M. The position accounts for 0.15% of the portfolio, ranked #122.

Mizuho Securities USA first reported a position in BMY in Q4 2014 and has held it in 13 quarters since. The position peaked at $20.4M in Q1 2017. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Mizuho Securities USA held 159,871 shares of Bristol-Myers Squibb worth $9.21M as of Q2 2026.
Mizuho Securities USA bought 36,757 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.11M.
Bristol-Myers Squibb made up 0.15% of Mizuho Securities USA's portfolio in Q2 2026, its #122 holding.
Mizuho Securities USA first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 13 quarters since.
Mizuho Securities USA's Bristol-Myers Squibb position peaked at $20.4M in Q1 2017.
2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.